NOV 01, 2017 9:00 AM PDT

WEBINAR: Clinical Applications and Strategies Using Procalcitonin (PCT) to Improve Patient Outcomes

Sponsored by: Abbott Molecular
Speaker
  • Director of Critical Services Swedish Covenant Hospital
    Biography
      Eric Howard Gluck, M.D. received his medical degree in medicine from New York Medical College in Valhalla, New York. He completed his residency at Beth Israel Medical Center in New York City and a pulmonary fellowship at the University of Utah School of Medicine in Salt Lake City, Utah. He currently serves as the director of Critical Care Services and Chief Academic Officer at Swedish Covenant Hospital in Chicago, Illinois. In addition, Dr. Gluck is a Professor of Medicine at the Finch University of Health Sciences/The Chicago Medical School. Dr. Gluck is part of many professional societies. Most notably, he is a fellow of the Society of Critical Care Medicine, the American College of Chest Physicians, and the Chicago Institute of Medicine. He is a member of the American Thoracic Society, the Society of Sigma Xi, Alpha Omega Alpha, and the American Society of Law, Medicine, and Ethics. He has presented lectures and authored many peer reviewed articles and chapters in the field of pulmonary critical care and has been in practice for more than 20 years. More recently, Dr. Gluck has been leader at developing and implementation strategies at his institution to reduce the risk of sepsis in critically ill patients.

    Abstract

    DATE:  November 1, 2017

    TIME:  9:00am PT, 12:00pm ET

    Over 1.6 million people are diagnosed with sepsis in the U.S. each year1 and sepsis is the #1 cost of hospitalization (over $24 billion each year)1. Having a biomarker that can quickly identify sepsis is critical because mortality increases 8% every hour that treatment is delayed1.

    Procalcitonin (PCT) helps determine if the patient has a bacterial infection (sepsis), the severity of the infection and is the patient responding to therapy2. PCT is a more accurate diagnostic parameter for sepsis and a better predictor of mortality and a more reliable marker than other biomarkers3. PCT also provides clinicians a mechanism for antibiotic stewardship2.

    1. Sepsis Alliance Website: http://www.sepsis.org/downloads/2017_sepsis_facts_media.pdf3
    2. Thermo Scientific B-R-A-H-M-S PCT Improving infection management.
    3. Shiferaw, et al. The Role of Procalcitonin as a Biomarker in Sepsis. J Infect Dis Epidemiology. 2016;2:006 Vol 2.

    Expected Outcomes:

    • Understand the clinical utility of PCT.
    • Incorporate  PCT protocols as part of sepsis management.
    • Demonstrate the impact PCT can have on clinical and financial outcomes

     


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources
    Attendees
    • See more